Literature DB >> 23553028

HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.

Weidong Chen1, Hua Zhao, Tiegang Li, Hongliang Yao.   

Abstract

The HFE gene has been suggested to play an important role in the pathogenesis of colorectal cancer. However, the results have been conflicting. In this study, we performed a meta-analysis to clarify the association of HFE gene C282Y variant with colorectal cancer. PubMed and Embase were retrieved to identify the potential literature. Pooled odds ratio (OR) with 95 % confidence interval (CI) was calculated using fixed- or random-effects model. A total of eight papers including nine studies (7,588 colorectal cancer cases and 81,571 controls) for HFE gene C282Y variant were included in the meta-analysis. The result indicated that HFE gene C282Y variant was significantly associated with colorectal cancer under recessive model (OR = 2.00, 95 % CI = 1.32-3.04), with no evidence of between-study heterogeneity (I (2) = 0.2 %, p = 0.432). Further subgroup analysis by number of cases suggested the effect was significant in studies with more than 500 cases (OR = 2.51, 95 % CI = 1.58-3.98, I (2) = 0.0 %, p = 0.921), but not in studies with less than 500 cases (OR = 0.75, 95 % CI = 0.28-1.97, I (2) = 0.0 %, p = 0.622). The current meta-analysis supported the positive association of HFE gene C282Y variant with colorectal cancer. Further large-scale studies with the consideration for gene-gene/gene-environment interactions should be conducted to investigate the association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553028     DOI: 10.1007/s13277-013-0766-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  Re: Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer.

Authors:  Jerome L Sullivan
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

2.  Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload.

Authors:  Silvia Fargion; Luca Valenti; Anna Ludovica Fracanzani
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

3.  No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation.

Authors:  G A Macdonald; J Tarish; V J Whitehall; S J McCann; G D Mellick; R L Buttenshaw; A G Johnson; J Young; B A Leggett
Journal:  J Gastroenterol Hepatol       Date:  1999-12       Impact factor: 4.029

4.  Heterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands).

Authors:  Daphne L van der A; Olga van der Hel; Mark Roest; Yvonne T van der Schouw; Carla H van Gils; Joannes J M Marx; Paulus A H van Noord; Petra H M Peeters
Journal:  Cancer Causes Control       Date:  2003-08       Impact factor: 2.506

Review 5.  Diagnosis and management of hemochromatosis.

Authors:  B R Bacon
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  Hemochromatosis gene mutations and distal adenomatous colorectal polyps.

Authors:  Katherine A McGlynn; Lori C Sakoda; Ying Hu; Robert E Schoen; Robert S Bresalier; Meredith Yeager; Stephen Chanock; Richard B Hayes; Kenneth H Buetow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

8.  Iron: an emerging factor in colorectal carcinogenesis.

Authors:  Anita C G Chua; Borut Klopcic; Ian C Lawrance; John K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

9.  HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.

Authors:  Nicholas J Osborne; Lyle C Gurrin; Katrina J Allen; Clare C Constantine; Martin B Delatycki; Christine E McLaren; Dorota M Gertig; Gregory J Anderson; Melissa C Southey; John K Olynyk; Lawrie W Powell; John L Hopper; Graham G Giles; Dallas R English
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

10.  Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer.

Authors:  Nicholas J Shaheen; Lawrence M Silverman; Temitope Keku; Laura B Lawrence; Elizabeth M Rohlfs; Christopher F Martin; Joseph Galanko; Robert S Sandler
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506

View more
  13 in total

1.  Toenail iron, genetic determinants of iron status, and the risk of glioma.

Authors:  Gabriella M Anic; Melissa H Madden; Reid C Thompson; L Burton Nabors; Jeffrey J Olson; Renato V Larocca; James E Browning; John D Brockman; Peter A Forsyth; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2013-08-31       Impact factor: 2.506

2.  Plasma ferritin levels, HFE polymorphisms, and risk of pancreatic cancer among Chinese Han population.

Authors:  Zhiming Zhao; Chenggang Li; Minggeng Hu; Jidong Li; Rong Liu
Journal:  Tumour Biol       Date:  2014-05-06

3.  Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.

Authors:  Agustin Castiella; Fernando Múgica; Eva Zapata; Leire Zubiaurre; Arantxa Iribarren; M Dolores de Juan; Luis Alzate; Ines Gil; Gregorio Urdapilleta; Pedro Otazua; José Ignacio Emparanza
Journal:  Tumour Biol       Date:  2015-04-09

4.  The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies.

Authors:  Xiang Tong; Jiqiao Yang; Yuanling Peng; Jiani Shen; Tianyuan Xiong; Yonggang Zhang; Hong Fan
Journal:  Tumour Biol       Date:  2013-10-06

5.  Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.

Authors:  Tatiana I Ivanova; Ludmila I Krikunova; Nikolay I Ryabchenko; Liana S Mkrtchyan; Vera A Khorokhorina; Lyubov E Salnikova
Journal:  Oxid Med Cell Longev       Date:  2015-02-09       Impact factor: 6.543

Review 6.  Evidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical Populations.

Authors:  Cody Weston; James Connor
Journal:  Transl Oncogenomics       Date:  2014-12-04

7.  Association Studies of HFE C282Y and H63D Variants with Oral Cancer Risk and Iron Homeostasis Among Whites and Blacks.

Authors:  Nathan R Jones; Joseph H Ashmore; Sang Y Lee; John P Richie; Philip Lazarus; Joshua E Muscat
Journal:  Cancers (Basel)       Date:  2015-12-09       Impact factor: 6.639

8.  The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.

Authors:  Yang-Fan Lv; Xian Chang; Rui-Xi Hua; Guang-Ning Yan; Gang Meng; Xiao-Yu Liao; Xi Zhang; Qiao-Nan Guo
Journal:  J Cell Mol Med       Date:  2016-02-19       Impact factor: 5.310

9.  Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data.

Authors:  Sang Y Lee; Junjia Zhu; Anna C Salzberg; Bo Zhang; Dajiang J Liu; Joshua E Muscat; Sara T Langan; James R Connor
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

Review 10.  Iron Metabolism in Cancer Progression.

Authors:  Stefania Forciniti; Luana Greco; Fabio Grizzi; Alberto Malesci; Luigi Laghi
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.